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Regulatory T-cells (T
reg
) have emerged as 
a crucial cellular checkpoint acting to pre-
vent potentially harmful immune responses. 
Due to its highly diverse activities, regulat-
ing the immune system requires more than 
general suppression. Particularly, during 
the developing immune response to infec-
tion, T
reg
 need to balance the host reaction 
to achieve both an effective response against 
the invading pathogen as well as to prevent 
immunopathology from excessive or inap-
propriate activity. In this opinion article we 
discuss the dual roles of IL-2 as both a key 
inducer of T
reg
 activity and also a target of T
reg
 
control  during the acute phase of infection. 
We propose a model in which Foxp3+ reg-
ulatory T-cells dynamically “measure” IL-2 
availability and restrict its access to effector 
T-cells, thereby controlling differentiation 
of these useful but potentially harmful cells.
CD4+ T-lymphocytes play a central 
role in orchestrating immune responses 
by modifying the functionality of other 
immune cells and guiding the qualita-
tive features of a response to one optimal 
for resisting a particular microorganism. 
Besides augmenting both innate and adap-
tive immune responses, CD4+ T-cells limit 
excessive immune activation and immuno-
pathology during infections. Among CD4+ 
T-cells, Foxp3+ regulatory T-cells (T
reg
) are 
essential for the maintenance of peripheral 
tolerance (Kim et al., 2007; Lahl et al., 2007). 
These cells also modulate the responses to 
pathogens (Belkaid and Tarbell, 2009). 
A plethora of mechanisms for how T
reg
 
exert their function have been suggested 
(Shevach, 2009; Josefowicz et al., 2012). 
However, there is still an ongoing debate as 
to which functions of T
reg
 are essential under 
which circumstances. Likely, T
reg
 function 
can be attuned to specific  conditions and 
distinct “rules” govern T
reg
 behavior in the 
steady-state versus inflammatory environ-
ments, secondary lymphoid (SLO) ver-
sus peripheral organs, developing versus 
ongoing immune responses, or acute ver-
sus chronic infections, for example. In this 
article we focus on the function of T
reg
 in 
the SLO during a developing acute infection 
and, although several cytokines are relevant, 
we concentrate on IL-2 as a central platform 
that enables effective immune control, as it 
(1) links activation of effector and regula-
tory responses, (2) establishes a feed-back 
loop for T-cell expansion, and (3) allows 
control over T-cell differentiation and fate 
decisions, preserving memory formation.
IL-2 Is a centraL cytokIne for 
t-ceLL actIvatIon
IL-2, originally discovered as a mitogenic 
factor for T-cells, is bound as a quaternary 
complex with CD25 (IL2Rα-chain), CD122 
(IL2Rβ-chain), and CD132 (common 
γ-chain). The α/β-heterodimer facilitates 
IL-2 capture with high affinity and, further 
stabilized by the γ-chain, forms a very stable 
complex which is terminated via receptor 
internalization rather than ligand dissocia-
tion (Smith, 2006). Upon activation by TCR 
interactions and additional co-stimulation 
via CD80/CD86, conventional T-cells (T
conv
) 
produce IL-2 and upregulate CD25 expres-
sion, which enhances IL-2 capture and con-
sequently IL-2 signaling, further promoting 
CD25 expression, T-cell activation, and pro-
liferation. This feed-forward loop can lead 
to activation-induced cell death, but highly 
activated, proliferating T-cells also undergo 
apoptosis when acutely deprived of IL-2 sig-
nals. Therefore, IL-2 is a master regulator of 
T-cell activation, proliferation, and death, 
excellently reviewed in Malek and Castro 
(2010), Boyman and Sprent (2012).
actIvatIon of treg through IL-2: 
antIcIpatIon and sensIng of 
effector responses
In contrast to conventional T-cells (T
conv
), 
T
reg
 constitutively express CD25 (Sakaguchi 
et al., 1995) and have STAT5 phosphoryla-
tion in the steady-state, arguing for con-
tinuous or high frequency intermittent 
IL-2 signaling in the absence of infection. 
Indeed, IL-2 signals seem to be pivotal 
for T
reg
 survival because animals that lack 
IL-2, CD25, or CD122 are largely devoid of 
peripheral T
reg
 and suffer from severe auto-
immunity (Sadlack et al., 1993; Suzuki et al., 
1995; Willerford et al., 1995; Fontenot et al., 
2005). T
reg
 do not produce IL-2 themselves 
when stimulated through the TCR and 
therefore rely on paracrine IL-2 for their 
maintenance. T
conv
 produce IL-2 upon acti-
vation and then gradually upregulate CD25. 
Since T
reg
 constitutively express CD25, they 
can sense and signal via IL-2 as soon as it 
is produced, assuming that these T
reg
 are 
within suitable proximity to the cytokine 
secreting cells. Because IL-2 signaling fur-
ther upregulates CD25, T
reg 
can even increase 
their ability to capture IL-2 as compared to 
T
conv 
which need to initiate CD25 expression 
post TCR-mediated activation (Feinerman 
et al., 2010). Indeed, it has been shown in 
vivo that T
reg
 are the first cells to respond 
to IL-2 upon antigenic challenge of T
conv
 
(O’Gorman et al., 2009). As the amount 
of IL-2 produced by T-cells correlates with 
the extent of co-stimulation from DC in 
vitro (Shahinian et al., 1993) and in vivo 
(Kastenmuller et al., 2011), it might reflect 
the magnitude of pathogen burden and the 
extent of innate stimulation. Therefore, T
reg
 
“sense” the initiation of an adaptive immune 
response in a qualitative and potentially 
quantitative manner when responding to 
IL-2 signals derived from adaptive effectors.
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treg seLectIveLy reguLate effector 
t-ceLL responses but preserve 
memory deveLopment
Recently, the effects of IL-2 during acute 
infection have been further refined through 
analysis of the role of this cytokine in the 
various stages of CD8+ T-cell differentiation. 
After their initial activation and induction of 
CD25 expression, a subpopulation of CD8+ 
T-cells decrease CD25 levels and become 
unresponsive to further IL-2 signals, and, at 
the same time, upregulate the IL-7Rα-chain 
and develop into long-lived memory cells. 
This is in contrast to T-cells that are exposed 
to IL-2 for a prolonged period and maintain 
CD25 expression, undergo enhanced expan-
sion, but differentiate into short-lived effec-
tor cells (SLEC) that are prone to apoptosis 
and severe population contraction after the 
peak of the response (Kalia et al., 2010; Obar 
et al., 2010; Pipkin et al., 2010). The recent 
development of genetic models allowing the 
specific depletion of Foxp3+ T
reg
 (Kim et al., 
2007; Lahl et al., 2007) without blocking 
IL-2/CD25 interactions (Murakami et al., 
2002; Suvas et al., 2003; Toka et al., 2004; 
Heit et al., 2008) enabled asking whether 
T
reg 
differentially affect these CD8+ T-cell 
subpopulations. Indeed, manipulating the 
numbers of activated T
reg
 in vivo impacted 
CD25 expression on activated CD8+ T-cells, 
indicative of altered IL-2 availability. This 
resulted in specific changes in numbers 
of SLEC while leaving the memory CD8+ 
T-cell compartment largely unaltered 
(Kastenmuller et al., 2011; McNally et al., 
2011). Interestingly, the “window of oppor-
tunity” for the regulation of CD8+ T-cell 
responses by T
reg
 overlapped with the time 
of CD25 expression on CD8+ T-cells: deple-
tion of T
reg
 cells as late as d2–3 post infection 
enhanced antigen-specific T-cell numbers in 
a viral infection model, but depletion later 
than d5 (when CD8+ T-cells do not express 
CD25) failed to do so (Kastenmuller et al., 
2011). In addition, enhanced expansion of 
SLEC in the absence of T
reg
 was abrogated 
through the neutralization of IL-2 (McNally 
et al., 2011). Therefore, by controlling the 
availability of IL-2, T
reg
 cells can act as 
rheostats that balance the differentiation 
and expansion of pathogen-specific CD8+ 
effector T-cells. Importantly, by selectively 
regulating SLEC over memory precur-
sor T-cells, which rapidly seem to become 
independent of IL-2 signals (d2–3), T
reg
 can 
limit the extent of acute effector responses 
of surface CTLA-4 on their surface and this 
molecule can directly block co-stimulatory 
molecules and CD28-CD80/86-interactions, 
or, via trans endocytosis, modulate the 
amount of CD80/86 that is displayed 
by DC (Wing et al., 2008; Qureshi et al., 
2011). Importantly, the amount of CTLA-4 
expressed on T
reg
 is again regulated by IL-2 
signals. Consequently, T
reg
 control the level 
of co-stimulation through CD80/CD86 sur-
face expression not only during steady-state 
(Schildknecht et al., 2010), but, importantly, 
also during highly inflammatory processes 
such as viral infection (Kastenmuller et al., 
2011).
Therefore, DC appear to constitute a 
platform on which both stimulation and 
regulation of conventional T-cells is exe-
cuted, with IL-2 being a central mediator 
that activates both T
eff
 and T
reg
. Feed-back 
loops involving the constitutive high levels 
of CD25 on T
regs
 and the IL-2-promoted 
upregulation of CTLA-4 on these cells oper-
ate in concert to restrict IL-2 availability to 
activated T
eff
, controlling their expansion, 
differentiation, and survival (Figure 1).
treg controL the avaILabILIty of IL-2
Given the relative abundance of T
reg
 in SLO, 
where adaptive responses are initiated and 
IL-2 is being produced, it seems likely that 
the “sensing” of IL-2 by T
reg
 consumes a sig-
nificant amount of the totally available IL-2. 
In this scenario, the mere presence of T
reg
 
could reduce IL-2 availability and limit T
eff
 
responses, without a need for active regula-
tion (cytokine-sink model). Indeed, the pres-
ence of T
reg
 leads to substantial competition 
for IL-2, resulting in impaired proliferation 
of T
eff
 cells in vitro. Competition was further 
demonstrated in vivo, with a primary effect 
on the survival of T
eff
 and not on their prolif-
eration (Pandiyan et al., 2007; Kastenmuller 
et al., 2011). T
reg
 also control IL-2 production 
(Thornton and Shevach, 1998), either by 
directly acting on T-cells (Bodor et al., 2007; 
Vaeth et al., 2011) or indirectly, through DC 
(Onishi et al., 2008). The latter concept is 
based on in vitro evidence of a positive cor-
relation between IL-2 production by Teff, 
the strength of ConA stimulation, and the 
amount of CD28 expression (Shahinian 
et al., 1993). T
reg
 express significant levels 
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Figure 1 | Treg sense iL-2 early during immune responses and restrict cytokine availability to control 
T-cell fates. Left panel: TCR signals (not depicted) and co-stimulatory signals via CD80/86 activate naïve 
T-cells to upregulate CD25 and produce IL-2. Treg have constitutive expression of CD25, which enables them 
to “sense” early (d0) production of IL-2 and become activated. Right panel: Once activated T-cells divide, 
they become heterogeneous for CD25 expression (d2–4): a fraction of cells downregulates CD25, avoiding 
further IL-2 signals – and potentially regulation through Treg – in order to differentiate into long-lived memory 
cells (MPEC or TH-1CM), follicular helper cells or TH-17 cells, or they maintain CD25 expression for prolonged 
IL-2 signals to undergo terminal effector differentiation. Treg can balance this differentiation processes by 
regulating the availability of IL-2 via multiple mechanisms, among them (1) the blocking and reduction of 
CD80/86 via CTLA-4, (2) the direct inhibition of IL-2 production by T-cells, (3) the competition for IL-2, and (4) 
the consumption and degradation of IL-2.
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through interference with co-stimulatory 
molecule availability on DC, as well as 
by reducing its abundance through con-
sumption. Importantly, this does not act to 
simply blunt the overall immune response 
but selectively impacts on T-cell fates that 
require larger amounts of IL-2. In contrast, 
other T-cell subpopulations, such as mem-
ory-precursors or T
FH
, are not suppressed, 
allowing for the generation of cellular and 
humoral immunological memory to pro-
tect the host from future pathogen encoun-
ters (Figure 1). T
reg
 are therefore not merely 
immunosuppressive, they actively partici-
pate in guiding the differentiation and fate 
decisions of other T-cells by regulating the 
availability of IL-2 in SLO. In this regard, 
T
reg
 controlling IL-2 availability remind us 
of the three Moirai (the  incarnation of des-
tiny in greek mythology) who controlled 
the thread of life and thereby directed the 
fate of individuals.
In addition to this early regulation of 
effector responses through IL-2, T
reg
 can 
undergo functional specialization that 
parallels the differentiation of conventional 
CD4+ T-cells in terms of transcription fac-
tor usage and expression of chemokine 
receptors important for homing to periph-
eral sites (Chaudhry et al., 2009; Koch et al., 
2009; Zheng et al., 2009; Chung et al., 2011; 
Linterman et al., 2011). This differentiation 
might facilitate T
reg 
control of fully differ-
entiated effector cells in infected tissues, 
which is likely to involve mechanisms dis-
tinct from regulating or competing for IL-2 
(Soper et al., 2007), such as the production 
of immunosuppressive cytokines (Rubtsov 
et al., 2008) or cytotoxic molecules (Cao 
et al., 2007; Loebbermann et al., 2012).
Based on the emerging picture of selec-
tive control of effector T-cell fates, we specu-
late that interfering with T
reg
 function will 
help to optimize short-term immunothera-
peutic approaches, but might be less prom-
ising to increase the efficacy of prophylactic 
vaccines aiming at the induction of long-
term memory through T- and B-cells.
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without blunting the development of long-
lived memory (Kastenmuller et al., 2011). 
However, once memory is formed and the 
host is re-challenged with a pathogen, T
reg
 
can again control the expansion of second-
ary effector cells adapted to the extent and 
requirements of the current infection.
treg medIated restrIctIon of IL-2 as 
a generaL mechanIsm to reguLate 
fate decIsIons In t-ceLLs
Beyond CD8+ T-cells, IL-2 likely serves as 
a central element that allows T
reg
 to regu-
late population size and differentiation of 
T-cells in general. A series of recent studies 
have established the role of IL-2 in CD4+ 
T-cell differentiation into T
H1
, T
H2
, T
H17
, 
and T
FH
 cells (Liao et al., 2011; Boyman 
and Sprent, 2012). As with CD8+ T-cells 
discussed above, CD4+ T-cells segregate 
into CD25high and CD25low cells within the 
first days of a response to an acute infec-
tion, and prolonged IL-2 signals in CD25high 
cells leads to terminal differentiation and 
Blimp1 and T-bet upregulation in CD4+ 
effector cells. In contrast, CD25low cells gave 
rise to long-lived CXCR5highCCR7highT-betlow 
precursors of central memory cells, as well 
as CXCR5highBcl6high follicular T-helper cells 
(T
FH
; Choi et al., 2011; Pepper et al., 2011). 
In line with this, T
reg
 limit the expansion of 
antiviral CD4+ during acute infection, yet 
do not influence the generation of neutral-
izing antibodies (Kastenmuller et al., 2011).
Therefore, by limiting excessive IL-2, 
T
reg
 might not only blunt T
eff
 response but 
also ensure the generation of T
FH
 cells and 
consequently the development of appropri-
ate humoral immunity early during acute 
infection, as IL-2 signals negatively regulate 
T
FH 
differentiation (Ballesteros-Tato et al., 
2012; Johnston et al., 2012). By restrict-
ing IL-2 during acute infection, T
reg
 might 
additionally enhance mucosal immunity 
and regeneration (potentially preventing 
superinfection) through promotion of T
H17
 
generation, because production of this class 
of effector cells is inhibited by IL-2 (Chen 
et al., 2011; Pandiyan et al., 2011).
summary and perspectIve
In summary, we propose a model in which 
IL-2 availability is a central factor that 
controls the magnitude and shapes the 
character of adaptive immune responses. 
T
reg
 control access of other T-cells to this 
crucial cytokine by limiting its production 
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